What is Implicity?
Implicity provides a sophisticated AI-powered remote monitoring and research platform designed for Independent Diagnostic Testing Facilities and cardiac electrophysiology centers globally. The platform's core function is to aggregate, normalize, and standardize data from any implantable cardiac device, regardless of the manufacturer. This capability enables healthcare providers to deliver advanced, high-quality care to patients with connected CIEDs, facilitating proactive management and improved patient outcomes. The company's focus on interoperability and data standardization positions it as a key player in the digital health and remote patient monitoring landscape.
How much funding has Implicity raised?
Implicity has raised a total of $23M across 1 funding round:
Series A
$23M
Series A (2022): $23M with participation from Karista, BNP Paribas Development, XAnge, Feedaxess, Bpifrance, and Serena
Key Investors in Implicity
Karista
Karista is an entity focused on assisting individuals in finding suitable home care or disability support services, indicating a potential interest in health-tech solutions that improve patient well-being and access to care.
XAnge
XAnge is a European early-stage venture capital firm with extensive experience in backing transformative startups from Seed to Series B, suggesting a strategic interest in innovative technology companies with high growth potential.
Bpifrance
Bpifrance is a French public investment bank that supports companies at all stages of development, including innovation and international expansion, indicating a focus on fostering French technological advancement and global competitiveness.
What's next for Implicity?
With the recent Series A financing and a major strategic investment, Implicity is poised for significant expansion and further development of its AI-driven platform. The substantial capital raised will likely fuel advancements in its technological capabilities, enhance its market reach, and potentially support strategic partnerships within the healthcare ecosystem. The company's focus on improving care for patients with connected CIEDs aligns with the broader industry trend towards value-based care and remote patient management, suggesting a strong growth trajectory ahead. Future endeavors may include expanding its service offerings, penetrating new geographical markets, and further integrating AI for predictive analytics in cardiac care.
See full Implicity company page
